Scientists hunt for clues to predict breast cancer treatment response
NCT ID NCT07387861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at stored tumor samples from 70 women with a common type of breast cancer (ER-positive, HER2-negative) who received hormone therapy. Researchers want to see if two specific proteins, p-AKT and p-S6, can help tell which cancers will respond to treatment and which will not. The goal is to find better ways to personalize breast cancer care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER - ER+, HER2-, PIK3CA GENE MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.